Quinn Grainne 4
4 · PERRIGO Co plc · Filed Mar 8, 2024
Insider Transaction Report
Form 4
PERRIGO Co plcPRGO
Quinn Grainne
EVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2024-03-06$28.09/sh+1,759$49,410→ 20,914 total - Tax Payment
Ordinary Shares
2024-03-06$28.09/sh−915$25,702→ 19,999 total - Exercise/Conversion
Ordinary Shares
2024-03-07$29.69/sh+2,249$66,773→ 22,248 total - Tax Payment
Ordinary Shares
2024-03-07$29.69/sh−1,170$34,737→ 21,078 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2024-03-06−1,759→ 3,517 total→ Ordinary Shares (1,759 underlying) - Exercise/Conversion
Restricted Stock Units
[F1][F3]2024-03-07−2,249→ 2,249 total→ Ordinary Shares (2,249 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2024.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 March 2023.
Signature
/s/ Victor Torres, attorney-in-fact for Ms. Grainne Quinn|2024-03-08